NEW YORK (GenomeWeb News) - Japanese pharmaceutical company Eisai has licensed Rosetta Biosoftware's Elucidator protein expression and biomarker discovery system, Rosetta said yesterday.
 
Seattle-based Rosetta said Eisai plans to use the Elucidator system to support LC/MS methods for biomarker research in neurology at the Laboratory of Seeds Finding Technology
 
Elucidator enables data management and analysis workflow for comparative proteomics, Rosetta said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.